GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $206,000 | -22.6% | 4,735 | -22.4% | 0.03% | -12.1% |
| Q1 2022 | $266,000 | +1.9% | 6,103 | +3.2% | 0.03% | +3.1% |
| Q4 2021 | $261,000 | +13.0% | 5,913 | -2.2% | 0.03% | +3.2% |
| Q3 2021 | $231,000 | +14.4% | 6,045 | +6.7% | 0.03% | -24.4% |
| Q1 2021 | $202,000 | -1.5% | 5,664 | +0.4% | 0.04% | -14.6% |
| Q4 2020 | $205,000 | -8.1% | 5,640 | -4.7% | 0.05% | -21.3% |
| Q3 2020 | $223,000 | -19.5% | 5,921 | -13.3% | 0.06% | -26.5% |
| Q2 2020 | $277,000 | +8.6% | 6,829 | +1.5% | 0.08% | -9.8% |
| Q1 2020 | $255,000 | -21.1% | 6,725 | -2.0% | 0.09% | 0.0% |
| Q4 2019 | $323,000 | +6.6% | 6,861 | -2.9% | 0.09% | -2.1% |
| Q3 2019 | $303,000 | +7.1% | 7,068 | -0.5% | 0.09% | +16.0% |
| Q2 2019 | $283,000 | +26.9% | 7,104 | +34.0% | 0.08% | +22.7% |
| Q1 2019 | $223,000 | +11.5% | 5,300 | +10.9% | 0.07% | -31.2% |
| Q1 2017 | $200,000 | – | 4,779 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |